JAGX: Jaguar Health, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 9.24
Enterprise Value ($M) 31.57
Book Value ($M) 15.58
Book Value / Share 1.32
Price / Book 0.59
NCAV ($M) -6.24
NCAV / Share -0.53
Price / NCAV -1.48

Profitability (mra)
Return on Invested Capital (ROIC) -0.75
Return on Assets (ROA) -0.83
Return on Equity (ROE) -26.65

Liquidity (mrq)
Quick Ratio 1.36
Current Ratio 1.84

Balance Sheet (mrq) ($M)
Current Assets 36.64
Assets 58.47
Liabilities 42.88
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
07-22 13G/A Iliad Research & Trading, L.P. 9.13 102.12

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-05-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-04-17 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1)
2024-04-01 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-11-27 42,048 113,292 37.11
2024-11-26 27,287 74,531 36.61
2024-11-25 41,750 176,594 23.64
2024-11-22 128,561 244,958 52.48

(click for more detail)

Similar Companies
INTS – Intensity Therapeutics, Inc. IRD – Opus Genetics, Inc.
ITRM – Iterum Therapeutics plc JSPR – Jasper Therapeutics, Inc.
KALA – KALA BIO, Inc.


Financial data and stock pages provided by
Fintel.io